Loading…

Ubiquitin and Legionella: From bench to bedside

Legionella pneumophila, a Gram-negative intracellular bacterium, is one of the major causes of Legionnaires’ disease, a specific type of atypical pneumonia. Despite intensive research efforts that elucidated many relevant structural, molecular and medical insights into Legionella’s pathogenicity, Le...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in cell & developmental biology 2022-12, Vol.132, p.230-241
Main Authors: Tomaskovic, Ines, Gonzalez, Alexis, Dikic, Ivan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943
cites cdi_FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943
container_end_page 241
container_issue
container_start_page 230
container_title Seminars in cell & developmental biology
container_volume 132
creator Tomaskovic, Ines
Gonzalez, Alexis
Dikic, Ivan
description Legionella pneumophila, a Gram-negative intracellular bacterium, is one of the major causes of Legionnaires’ disease, a specific type of atypical pneumonia. Despite intensive research efforts that elucidated many relevant structural, molecular and medical insights into Legionella’s pathogenicity, Legionnaires’ disease continues to present an ongoing public health concern. Legionella’s virulence is based on its ability to simultaneously hijack multiple molecular pathways of the host cell to ensure its fast replication and dissemination. Legionella usurps the host ubiquitin system through multiple effector proteins, using the advantage of both conventional and unconventional (phosphoribosyl-linked) ubiquitination, thus providing optimal conditions for its replication. In this review, we summarize the current understanding of L. pneumophila from medical, biochemical and molecular perspectives. We describe the clinical disease presentation, its diagnostics and treatment, as well as host-pathogen interactions, with the emphasis on the ability of Legionella to target the host ubiquitin system upon infection. Furthermore, the interdisciplinary use of innovative technologies enables better insights into the pathogenesis of Legionnaires’ disease and provides new opportunities for its treatment and prevention. •Outbreaks of L. pneumophila represent an ongoing public health care problem.•Host-pathogen interplay is tightly coordinated by Legionella effector proteins.•L. pneumophila hijacks the host ubiquitin system using both canonical and non-canonical phosphoribosyl-linked ubiquitination.•State-of-the-art techniques provide new insights into L. pneumophila pathogenesis, enabling novel translational approaches.
doi_str_mv 10.1016/j.semcdb.2022.02.008
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2630920982</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1084952122000489</els_id><sourcerecordid>2630920982</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943</originalsourceid><addsrcrecordid>eNp9kE1PwzAMhiMEYjD4Bwj1yKWb89Gs4YCEJgZIk7iwc9Q2DmRa2y1pkfj3pOrgiGzJPrz2az-E3FCYUaByvp0FrCtTzhgwNoOYkJ-QCwpKplxycTr0uUhVxuiEXIawBQChmDwnE57RxYKL_ILMN6U79K5zTVI0Jlnjh2sb3O2K-2Tl2zopsak-k66NjQnO4BU5s8Uu4PWxTslm9fS-fEnXb8-vy8d1WgnIu1RmhQFAIa0FYDwbwjLM7ILl1nLBmaKSWikrKm1WKLTKKEY5taygUgk-JXfj3r1vDz2GTtcuVMNhDbZ90ExyUAxUzqJUjNLKtyF4tHrvXV34b01BD6j0Vo-o9IBKQ0zI49jt0aEvazR_Q79souBhFGD888uh16FyEQca57HqtGnd_w4_98t5JA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2630920982</pqid></control><display><type>article</type><title>Ubiquitin and Legionella: From bench to bedside</title><source>ScienceDirect Freedom Collection</source><creator>Tomaskovic, Ines ; Gonzalez, Alexis ; Dikic, Ivan</creator><creatorcontrib>Tomaskovic, Ines ; Gonzalez, Alexis ; Dikic, Ivan</creatorcontrib><description>Legionella pneumophila, a Gram-negative intracellular bacterium, is one of the major causes of Legionnaires’ disease, a specific type of atypical pneumonia. Despite intensive research efforts that elucidated many relevant structural, molecular and medical insights into Legionella’s pathogenicity, Legionnaires’ disease continues to present an ongoing public health concern. Legionella’s virulence is based on its ability to simultaneously hijack multiple molecular pathways of the host cell to ensure its fast replication and dissemination. Legionella usurps the host ubiquitin system through multiple effector proteins, using the advantage of both conventional and unconventional (phosphoribosyl-linked) ubiquitination, thus providing optimal conditions for its replication. In this review, we summarize the current understanding of L. pneumophila from medical, biochemical and molecular perspectives. We describe the clinical disease presentation, its diagnostics and treatment, as well as host-pathogen interactions, with the emphasis on the ability of Legionella to target the host ubiquitin system upon infection. Furthermore, the interdisciplinary use of innovative technologies enables better insights into the pathogenesis of Legionnaires’ disease and provides new opportunities for its treatment and prevention. •Outbreaks of L. pneumophila represent an ongoing public health care problem.•Host-pathogen interplay is tightly coordinated by Legionella effector proteins.•L. pneumophila hijacks the host ubiquitin system using both canonical and non-canonical phosphoribosyl-linked ubiquitination.•State-of-the-art techniques provide new insights into L. pneumophila pathogenesis, enabling novel translational approaches.</description><identifier>ISSN: 1084-9521</identifier><identifier>EISSN: 1096-3634</identifier><identifier>DOI: 10.1016/j.semcdb.2022.02.008</identifier><identifier>PMID: 35177348</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Autophagy, novel technologies ; Bacterial Proteins - metabolism ; Conventional and unconventional ubiquitination ; Host-Pathogen Interactions ; Humans ; Legionella pneumophila ; Legionella pneumophila - metabolism ; Legionnaires' Disease - microbiology ; Legionnaires' Disease - pathology ; Ubiquitin - metabolism</subject><ispartof>Seminars in cell &amp; developmental biology, 2022-12, Vol.132, p.230-241</ispartof><rights>2022</rights><rights>Copyright © 2022. Published by Elsevier Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943</citedby><cites>FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35177348$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tomaskovic, Ines</creatorcontrib><creatorcontrib>Gonzalez, Alexis</creatorcontrib><creatorcontrib>Dikic, Ivan</creatorcontrib><title>Ubiquitin and Legionella: From bench to bedside</title><title>Seminars in cell &amp; developmental biology</title><addtitle>Semin Cell Dev Biol</addtitle><description>Legionella pneumophila, a Gram-negative intracellular bacterium, is one of the major causes of Legionnaires’ disease, a specific type of atypical pneumonia. Despite intensive research efforts that elucidated many relevant structural, molecular and medical insights into Legionella’s pathogenicity, Legionnaires’ disease continues to present an ongoing public health concern. Legionella’s virulence is based on its ability to simultaneously hijack multiple molecular pathways of the host cell to ensure its fast replication and dissemination. Legionella usurps the host ubiquitin system through multiple effector proteins, using the advantage of both conventional and unconventional (phosphoribosyl-linked) ubiquitination, thus providing optimal conditions for its replication. In this review, we summarize the current understanding of L. pneumophila from medical, biochemical and molecular perspectives. We describe the clinical disease presentation, its diagnostics and treatment, as well as host-pathogen interactions, with the emphasis on the ability of Legionella to target the host ubiquitin system upon infection. Furthermore, the interdisciplinary use of innovative technologies enables better insights into the pathogenesis of Legionnaires’ disease and provides new opportunities for its treatment and prevention. •Outbreaks of L. pneumophila represent an ongoing public health care problem.•Host-pathogen interplay is tightly coordinated by Legionella effector proteins.•L. pneumophila hijacks the host ubiquitin system using both canonical and non-canonical phosphoribosyl-linked ubiquitination.•State-of-the-art techniques provide new insights into L. pneumophila pathogenesis, enabling novel translational approaches.</description><subject>Autophagy, novel technologies</subject><subject>Bacterial Proteins - metabolism</subject><subject>Conventional and unconventional ubiquitination</subject><subject>Host-Pathogen Interactions</subject><subject>Humans</subject><subject>Legionella pneumophila</subject><subject>Legionella pneumophila - metabolism</subject><subject>Legionnaires' Disease - microbiology</subject><subject>Legionnaires' Disease - pathology</subject><subject>Ubiquitin - metabolism</subject><issn>1084-9521</issn><issn>1096-3634</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PwzAMhiMEYjD4Bwj1yKWb89Gs4YCEJgZIk7iwc9Q2DmRa2y1pkfj3pOrgiGzJPrz2az-E3FCYUaByvp0FrCtTzhgwNoOYkJ-QCwpKplxycTr0uUhVxuiEXIawBQChmDwnE57RxYKL_ILMN6U79K5zTVI0Jlnjh2sb3O2K-2Tl2zopsak-k66NjQnO4BU5s8Uu4PWxTslm9fS-fEnXb8-vy8d1WgnIu1RmhQFAIa0FYDwbwjLM7ILl1nLBmaKSWikrKm1WKLTKKEY5taygUgk-JXfj3r1vDz2GTtcuVMNhDbZ90ExyUAxUzqJUjNLKtyF4tHrvXV34b01BD6j0Vo-o9IBKQ0zI49jt0aEvazR_Q79souBhFGD888uh16FyEQca57HqtGnd_w4_98t5JA</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Tomaskovic, Ines</creator><creator>Gonzalez, Alexis</creator><creator>Dikic, Ivan</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>Ubiquitin and Legionella: From bench to bedside</title><author>Tomaskovic, Ines ; Gonzalez, Alexis ; Dikic, Ivan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Autophagy, novel technologies</topic><topic>Bacterial Proteins - metabolism</topic><topic>Conventional and unconventional ubiquitination</topic><topic>Host-Pathogen Interactions</topic><topic>Humans</topic><topic>Legionella pneumophila</topic><topic>Legionella pneumophila - metabolism</topic><topic>Legionnaires' Disease - microbiology</topic><topic>Legionnaires' Disease - pathology</topic><topic>Ubiquitin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tomaskovic, Ines</creatorcontrib><creatorcontrib>Gonzalez, Alexis</creatorcontrib><creatorcontrib>Dikic, Ivan</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Seminars in cell &amp; developmental biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tomaskovic, Ines</au><au>Gonzalez, Alexis</au><au>Dikic, Ivan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ubiquitin and Legionella: From bench to bedside</atitle><jtitle>Seminars in cell &amp; developmental biology</jtitle><addtitle>Semin Cell Dev Biol</addtitle><date>2022-12</date><risdate>2022</risdate><volume>132</volume><spage>230</spage><epage>241</epage><pages>230-241</pages><issn>1084-9521</issn><eissn>1096-3634</eissn><abstract>Legionella pneumophila, a Gram-negative intracellular bacterium, is one of the major causes of Legionnaires’ disease, a specific type of atypical pneumonia. Despite intensive research efforts that elucidated many relevant structural, molecular and medical insights into Legionella’s pathogenicity, Legionnaires’ disease continues to present an ongoing public health concern. Legionella’s virulence is based on its ability to simultaneously hijack multiple molecular pathways of the host cell to ensure its fast replication and dissemination. Legionella usurps the host ubiquitin system through multiple effector proteins, using the advantage of both conventional and unconventional (phosphoribosyl-linked) ubiquitination, thus providing optimal conditions for its replication. In this review, we summarize the current understanding of L. pneumophila from medical, biochemical and molecular perspectives. We describe the clinical disease presentation, its diagnostics and treatment, as well as host-pathogen interactions, with the emphasis on the ability of Legionella to target the host ubiquitin system upon infection. Furthermore, the interdisciplinary use of innovative technologies enables better insights into the pathogenesis of Legionnaires’ disease and provides new opportunities for its treatment and prevention. •Outbreaks of L. pneumophila represent an ongoing public health care problem.•Host-pathogen interplay is tightly coordinated by Legionella effector proteins.•L. pneumophila hijacks the host ubiquitin system using both canonical and non-canonical phosphoribosyl-linked ubiquitination.•State-of-the-art techniques provide new insights into L. pneumophila pathogenesis, enabling novel translational approaches.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35177348</pmid><doi>10.1016/j.semcdb.2022.02.008</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1084-9521
ispartof Seminars in cell & developmental biology, 2022-12, Vol.132, p.230-241
issn 1084-9521
1096-3634
language eng
recordid cdi_proquest_miscellaneous_2630920982
source ScienceDirect Freedom Collection
subjects Autophagy, novel technologies
Bacterial Proteins - metabolism
Conventional and unconventional ubiquitination
Host-Pathogen Interactions
Humans
Legionella pneumophila
Legionella pneumophila - metabolism
Legionnaires' Disease - microbiology
Legionnaires' Disease - pathology
Ubiquitin - metabolism
title Ubiquitin and Legionella: From bench to bedside
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A10%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ubiquitin%20and%20Legionella:%20From%20bench%20to%20bedside&rft.jtitle=Seminars%20in%20cell%20&%20developmental%20biology&rft.au=Tomaskovic,%20Ines&rft.date=2022-12&rft.volume=132&rft.spage=230&rft.epage=241&rft.pages=230-241&rft.issn=1084-9521&rft.eissn=1096-3634&rft_id=info:doi/10.1016/j.semcdb.2022.02.008&rft_dat=%3Cproquest_cross%3E2630920982%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-65ad00e46ff002353535f2e5f728ff34329161f66c16f5a9ef9d92131f2a16943%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2630920982&rft_id=info:pmid/35177348&rfr_iscdi=true